Yamamoto M - Search Results

1

[Effects of preserved erythrocytes and activated-preserved erythrocytes with phosphoenolpyruvate on energy metabolism in rat ischemic brain tissue].

Ueno Y, Hamasaki N, Kimura H, Yamamoto M, Tomonaga M. Ueno Y, et al. Among authors: yamamoto m. No To Shinkei. 2001 Jun;53(6):551-8. No To Shinkei. 2001. PMID: 11436340 Japanese.

2

Circulation of red blood cells having high levels of 2,3-bisphosphoglycerate protects rat brain from ischemic metabolic changes during hemodilution.

Kimura H, Hamasaki N, Yamamoto M, Tomonaga M. Kimura H, et al. Among authors: yamamoto m. Stroke. 1995 Aug;26(8):1431-6; discussion 1436-7. doi: 10.1161/01.str.26.8.1431. Stroke. 1995. PMID: 7631349

3

Fructose 2,6-bisphosphate changes in rat brain during ischemia.

Yamamoto M, Hamasaki N, Maruta Y, Tomonaga M. Yamamoto M, et al. J Neurochem. 1990 Feb;54(2):592-7. doi: 10.1111/j.1471-4159.1990.tb01912.x. J Neurochem. 1990. PMID: 2153755

4

Treatment of bacterial brain abscess by repeated aspiration--follow up by serial computed tomography.

Yamamoto M, Fukushima T, Hirakawa K, Kimura H, Tomonaga M. Yamamoto M, et al. Neurol Med Chir (Tokyo). 2000 Feb;40(2):98-104; discussion 104-5. doi: 10.2176/nmc.40.98. Neurol Med Chir (Tokyo). 2000. PMID: 10786097 Free article.

5

Expression of nuclear factor kappaB and tumor necrosis factor alpha in the mouse brain after experimental thermal ablation injury.

Nomoto Y, Yamamoto M, Fukushima T, Kimura H, Ohshima K, Tomonaga M. Nomoto Y, et al. Among authors: yamamoto m. Neurosurgery. 2001 Jan;48(1):158-66. doi: 10.1097/00006123-200101000-00027. Neurosurgery. 2001. PMID: 11152341

6

Fructose 2,6-bisphosphate in human erythrocytes.

Moriyasu M, Yamamoto M, Hamasaki N. Moriyasu M, et al. Among authors: yamamoto m. J Biochem. 1988 Jun;103(6):903-4. doi: 10.1093/oxfordjournals.jbchem.a122384. J Biochem. 1988. PMID: 3170520 Free article.

7

Red blood cell function and blood storage.

Hamasaki N, Yamamoto M. Hamasaki N, et al. Among authors: yamamoto m. Vox Sang. 2000;79(4):191-7. doi: 10.1159/000056729. Vox Sang. 2000. PMID: 11155068 Review.

8

The clinical significance of cerebral veins in moyamoya disease.

Kimura H, Oka K, Ikeda K, Yamamoto M, Tomonaga M. Kimura H, et al. Among authors: yamamoto m. Clin Neurol Neurosurg. 1997 Oct;99 Suppl 2:S90-5. doi: 10.1016/s0303-8467(97)00064-4. Clin Neurol Neurosurg. 1997. PMID: 9409414

9

Treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2).

Fukushima T, Yamamoto M, Ikeda K, Tsugu H, Kimura H, Soma G, Tomonaga M. Fukushima T, et al. Among authors: yamamoto m. Anticancer Res. 1998 Sep-Oct;18(5D):3965-70. Anticancer Res. 1998. PMID: 9854511 Clinical Trial.

10

Expression and cellular localization of low-density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor in human glioblastoma in vivo.

Yamamoto M, Ikeda K, Ohshima K, Tsugu H, Kimura H, Tomonaga M. Yamamoto M, et al. Brain Tumor Pathol. 1998;15(1):23-30. doi: 10.1007/BF02482097. Brain Tumor Pathol. 1998. PMID: 9879460

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,372 results

Search Page

Filters